Cargando…

Predictors of neonatal abstinence syndrome in buprenorphine exposed newborn: can cord blood buprenorphine metabolite levels help?

BACKGROUND: Buprenorphine is a semi-synthetic opioid used for the treatment of opioid dependence. Opioid use, including buprenorphine, has been increasing in recent years, in the general population and in pregnant women. Consequently, there has been a rise in frequency of neonatal abstinence syndrom...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Darshan, Brown, Stacy, Hagemeier, Nick, Zheng, Shimin, Kyle, Amy, Pryor, Jason, Dankhara, Nilesh, Singh, Piyuesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919189/
https://www.ncbi.nlm.nih.gov/pubmed/27386303
http://dx.doi.org/10.1186/s40064-016-2576-8
_version_ 1782439217279795200
author Shah, Darshan
Brown, Stacy
Hagemeier, Nick
Zheng, Shimin
Kyle, Amy
Pryor, Jason
Dankhara, Nilesh
Singh, Piyuesh
author_facet Shah, Darshan
Brown, Stacy
Hagemeier, Nick
Zheng, Shimin
Kyle, Amy
Pryor, Jason
Dankhara, Nilesh
Singh, Piyuesh
author_sort Shah, Darshan
collection PubMed
description BACKGROUND: Buprenorphine is a semi-synthetic opioid used for the treatment of opioid dependence. Opioid use, including buprenorphine, has been increasing in recent years, in the general population and in pregnant women. Consequently, there has been a rise in frequency of neonatal abstinence syndrome (NAS), associated with buprenorphine use during pregnancy. The purpose of this study was to investigate correlations between buprenorphine and buprenorphine-metabolite concentrations in cord blood and onset of NAS in buprenorphine exposed newborns. METHODS: Nineteen (19) newborns who met inclusion criteria were followed after birth until discharge in a double-blind non-intervention study, after maternal consent. Cord blood and tissue samples were collected and analyzed by liquid chromatography–mass spectrometry (LC–MS) for buprenorphine and metabolites. Simple and multiple logistic regressions were used to examine relationships between buprenorphine and buprenorphine metabolite concentrations in cord blood and onset of NAS, need for morphine therapy, and length of stay. RESULTS: Each increase in 5 ng/ml level of norbuprenorphine in cord blood increases odds of requiring treatment by morphine 2.5 times. Each increase in 5 ng/ml of buprenorphine-glucuronide decreases odds of receiving morphine by 57.7 %. Along with concentration of buprenorphine metabolites, birth weight and gestational age also play important roles, but not maternal buprenorphine dose. CONCLUSIONS: LC–MS analysis of cord blood concentrations of buprenorphine and metabolites is an effective way to examine drug and metabolite levels in the infant at birth. Cord blood concentrations of the active norbuprenorphine metabolite and the inactive buprenorphine-glucuronide metabolite show promise in predicting necessity of treatment of NAS. These finding have implications in improving patient care and reducing healthcare costs if confirmed in a larger sample.
format Online
Article
Text
id pubmed-4919189
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-49191892016-07-06 Predictors of neonatal abstinence syndrome in buprenorphine exposed newborn: can cord blood buprenorphine metabolite levels help? Shah, Darshan Brown, Stacy Hagemeier, Nick Zheng, Shimin Kyle, Amy Pryor, Jason Dankhara, Nilesh Singh, Piyuesh Springerplus Research BACKGROUND: Buprenorphine is a semi-synthetic opioid used for the treatment of opioid dependence. Opioid use, including buprenorphine, has been increasing in recent years, in the general population and in pregnant women. Consequently, there has been a rise in frequency of neonatal abstinence syndrome (NAS), associated with buprenorphine use during pregnancy. The purpose of this study was to investigate correlations between buprenorphine and buprenorphine-metabolite concentrations in cord blood and onset of NAS in buprenorphine exposed newborns. METHODS: Nineteen (19) newborns who met inclusion criteria were followed after birth until discharge in a double-blind non-intervention study, after maternal consent. Cord blood and tissue samples were collected and analyzed by liquid chromatography–mass spectrometry (LC–MS) for buprenorphine and metabolites. Simple and multiple logistic regressions were used to examine relationships between buprenorphine and buprenorphine metabolite concentrations in cord blood and onset of NAS, need for morphine therapy, and length of stay. RESULTS: Each increase in 5 ng/ml level of norbuprenorphine in cord blood increases odds of requiring treatment by morphine 2.5 times. Each increase in 5 ng/ml of buprenorphine-glucuronide decreases odds of receiving morphine by 57.7 %. Along with concentration of buprenorphine metabolites, birth weight and gestational age also play important roles, but not maternal buprenorphine dose. CONCLUSIONS: LC–MS analysis of cord blood concentrations of buprenorphine and metabolites is an effective way to examine drug and metabolite levels in the infant at birth. Cord blood concentrations of the active norbuprenorphine metabolite and the inactive buprenorphine-glucuronide metabolite show promise in predicting necessity of treatment of NAS. These finding have implications in improving patient care and reducing healthcare costs if confirmed in a larger sample. Springer International Publishing 2016-06-23 /pmc/articles/PMC4919189/ /pubmed/27386303 http://dx.doi.org/10.1186/s40064-016-2576-8 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Research
Shah, Darshan
Brown, Stacy
Hagemeier, Nick
Zheng, Shimin
Kyle, Amy
Pryor, Jason
Dankhara, Nilesh
Singh, Piyuesh
Predictors of neonatal abstinence syndrome in buprenorphine exposed newborn: can cord blood buprenorphine metabolite levels help?
title Predictors of neonatal abstinence syndrome in buprenorphine exposed newborn: can cord blood buprenorphine metabolite levels help?
title_full Predictors of neonatal abstinence syndrome in buprenorphine exposed newborn: can cord blood buprenorphine metabolite levels help?
title_fullStr Predictors of neonatal abstinence syndrome in buprenorphine exposed newborn: can cord blood buprenorphine metabolite levels help?
title_full_unstemmed Predictors of neonatal abstinence syndrome in buprenorphine exposed newborn: can cord blood buprenorphine metabolite levels help?
title_short Predictors of neonatal abstinence syndrome in buprenorphine exposed newborn: can cord blood buprenorphine metabolite levels help?
title_sort predictors of neonatal abstinence syndrome in buprenorphine exposed newborn: can cord blood buprenorphine metabolite levels help?
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919189/
https://www.ncbi.nlm.nih.gov/pubmed/27386303
http://dx.doi.org/10.1186/s40064-016-2576-8
work_keys_str_mv AT shahdarshan predictorsofneonatalabstinencesyndromeinbuprenorphineexposednewborncancordbloodbuprenorphinemetabolitelevelshelp
AT brownstacy predictorsofneonatalabstinencesyndromeinbuprenorphineexposednewborncancordbloodbuprenorphinemetabolitelevelshelp
AT hagemeiernick predictorsofneonatalabstinencesyndromeinbuprenorphineexposednewborncancordbloodbuprenorphinemetabolitelevelshelp
AT zhengshimin predictorsofneonatalabstinencesyndromeinbuprenorphineexposednewborncancordbloodbuprenorphinemetabolitelevelshelp
AT kyleamy predictorsofneonatalabstinencesyndromeinbuprenorphineexposednewborncancordbloodbuprenorphinemetabolitelevelshelp
AT pryorjason predictorsofneonatalabstinencesyndromeinbuprenorphineexposednewborncancordbloodbuprenorphinemetabolitelevelshelp
AT dankharanilesh predictorsofneonatalabstinencesyndromeinbuprenorphineexposednewborncancordbloodbuprenorphinemetabolitelevelshelp
AT singhpiyuesh predictorsofneonatalabstinencesyndromeinbuprenorphineexposednewborncancordbloodbuprenorphinemetabolitelevelshelp